Dow Chemical Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dow Chemical Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,000	Closed	-$1.99M	–	29
2016 Q4	$1.99M	Hold	30,000	–	–	0.21%	22
2016 Q3	$1.99M	Buy	30,000 +5,000	+20%	+$309K	0.19%	23
2016 Q2	$1.35M	Buy	+25,000	New	+$1.37M	0.14%	21

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Dow Chemical Company's XBI Position: Q1 2017 in Review

Dow Chemical Company sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2017, closing a stake of 30,000 shares — an estimated $1.99M sold.

Dow Chemical Company first reported a position in XBI in Q2 2016 and held it in 3 quarters. The position peaked at $1.99M in Q4 2016. 292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

Dow Chemical Company reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2017 after selling out during the quarter.
Dow Chemical Company sold 30,000 State Street SPDR S&P Biotech ETF shares in Q1 2017, an estimated $1.99M.
Dow Chemical Company first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 3 quarters.
Dow Chemical Company's State Street SPDR S&P Biotech ETF position peaked at $1.99M in Q4 2016.
292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on Dow Chemical Company's 13F filing for Q1 2017, filed 12 May 2017.